Generated by AI
Tonix Pharmaceuticals Holding Corp. is a biopharmaceutical company focused on developing and commercializing therapies for central nervous system disorders, immunology and immuno-oncology, infectious diseases, and rare diseases. Tonix Pharmaceuticals Holding Corp. markets approved and late-stage products for conditions with significant unmet medical need, including TONMYA for fibromyalgia and additional medicines used in migraine care. The company’s pipeline includes programs aimed at neurological, infectious, and immune-related diseases, reflecting a broad research and development platform built around small molecules and biologics. Tonix Pharmaceuticals Holding Corp. serves the U.S. healthcare market through a combination of commercial products, clinical development programs, and disease-focused collaborations. Its role in the financial market is defined by its position as a commercial-stage biotechnology business with a diversified therapeutic portfolio and ongoing pipeline activity.
Website200 Connell Drive
Berkeley Heights, NJ, 07928
United States
The latest articles about TNXP.
Summary of Nov 18's posts. Generated by AI.
Summary of Nov 18's posts. Generated by AI.
Summary of Mar 19's posts. Generated by AI.
Summary of Nov 13's posts. Generated by AI.
Investors talking about TNXP also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.